Detalhe da pesquisa
1.
First-In-Human, First-In-Class, Phase I Trial of the Fucosylation Inhibitor SGN-2FF in Patients with Advanced Solid Tumors.
Oncologist
; 26(11): 925-e1918, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34288257
2.
Lung Cancer in Nonelderly Patients: Facility and Patient Characteristics Associated With Not Receiving Treatment.
J Natl Compr Canc Netw
; 17(8): 931-939, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31390587
3.
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study.
Lancet Oncol
; 18(1): 42-51, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27932068
4.
Endoglin for targeted cancer treatment.
Curr Oncol Rep
; 16(2): 365, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24445497
5.
Docetaxel or pemetrexed with or without cetuximab in recurrent or progressive non-small-cell lung cancer after platinum-based therapy: a phase 3, open-label, randomised trial.
Lancet Oncol
; 14(13): 1326-36, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24231627
6.
Veliparib and nivolumab in combination with platinum doublet chemotherapy in patients with metastatic or advanced non-small cell lung cancer: A phase 1 dose escalation study.
Lung Cancer
; 161: 180-188, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34607210
7.
SWOG S1400A (NCT02154490): A Phase II Study of Durvalumab for Patients With Previously Treated Stage IV or Recurrent Squamous Cell Lung Cancer (Lung-MAP Sub-study).
Clin Lung Cancer
; 22(3): 178-186, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33358401
8.
A novel five-antibody immunohistochemical test for subclassification of lung carcinoma.
Mod Pathol
; 22(8): 1032-43, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19430419
9.
Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors.
Cancer Chemother Pharmacol
; 83(3): 551-559, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30603797
10.
Leukaemia cutis.
Lancet
; 380(9848): 1179, 2012 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-22704804
11.
A pilot study of zoledronic acid in the treatment of patients with advanced malignant pleural mesothelioma.
Lung Cancer (Auckl)
; 8: 39-44, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28652837
12.
Pilot phase II study of metronomic chemotherapy in combination with bevacizumab in patients with advanced non-squamous non-small cell lung cancer.
Lung Cancer
; 106: 125-130, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28285686
13.
Phase I Results from a Study of Crizotinib in Combination with Erlotinib in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer.
J Thorac Oncol
; 12(1): 145-151, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27697581
14.
Phase I/IIa study of cisplatin and gemcitabine as induction chemotherapy followed by concurrent chemoradiotherapy with gemcitabine and paclitaxel for locally advanced non-small-cell lung cancer.
J Clin Oncol
; 23(27): 6664-73, 2005 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-16170174
15.
Phase I/IIa study of cetuximab with gemcitabine plus carboplatin in patients with chemotherapy-naive advanced non-small-cell lung cancer.
J Clin Oncol
; 23(36): 9089-96, 2005 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-16301597
16.
Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men.
Chest
; 130(6): 1796-802, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17166999
17.
Phase II study of a novel taxane (Cabazitaxel-XRP 6258) in previously treated advanced non-small cell lung cancer (NSCLC) patients.
Cancer Chemother Pharmacol
; 78(3): 509-15, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27417317
18.
Individualized patient dosing in phase I clinical trials: the role of escalation with overdose control in PNU-214936.
J Clin Oncol
; 22(4): 602-9, 2004 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-14966084
19.
Phase I study of 90Y-CC49 monoclonal antibody therapy in patients with advanced non-small cell lung cancer: effect of chelating agents and paclitaxel co-administration.
Cancer Biother Radiopharm
; 20(5): 467-78, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16248762
20.
Phase I/IIa study of sequential chemotherapy regimen of bendamustine/irinotecan followed by etoposide/carboplatin in untreated patients with extensive disease small cell lung cancer (EDSCLC).
Cancer Chemother Pharmacol
; 76(5): 949-55, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26395450